Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
La Jolla Pharmaceutical Company is a biotechnology company developing therapeutics for antibody-mediated autoimmune diseases and inflammation afflicting several million people around the world. The Company is developing Riquent® for the treatment of lupus kidney disease, a leading cause of sickness and death in patients with lupus. The Company is also developing small molecules to treat various other autoimmune and inflammatory conditions. The Company’s common stock is traded on The Nasdaq Stock Market under the symbol LJPC. ( www.ljpc.com )
La Jolla Pharmaceutical Company
6455 Nancy Ridge Drive
San Diego, California 92121-2249
USA
Tel: (858) 452-6600
Fax: (858) 625-0155